T4b:

Yuho Ebata1, Ryota Nakanishi2, Yasushi Tanaka1

  • 1Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Anticancer research
|February 29, 2024
PubMed
概括

新辅助化疗 (NAC) 是可行的局部晚期结肠癌 (LACC) 与T4b或阻塞性T4a阶段. 这种治疗选择显示出有前途的结果,包括R0切除和降级,并具有可控的副作用.